Interestingly, the ex vivo treatment of T2DM HDLs with D-4F, an apoA-I mimetic peptide able to bind oxidized fatty acids, restores the antioxidant capacity of T2DM HDLs [81]. Here, APOA1 is linked to type 2 diabetes mellitus.